Excerpt
Some Americans have been buying prescription drugs abroad for less than it costs in the US. Both the House and Senate Medicare Reform packages would allow drug reimportation. The FDA says there are health concerns with reimporting drugs.
In This Issue
-
Foreword
Read More -
Recent Action in the Congress
May through September 2003
Read More -
Evolution of Current Law
Timeline of Drug Regulation in the United States
Read More -
Drug Importation Policy
Current Laws and Issues for Debate
Read More -
Safety Considerations
FDA Guidelines and Protections
Read More -
Interdiction Measures
Results of FDA/Customs "Blitzes"
Read More -
Prescription Drugs and Medicare
Rising Costs and Declining Spending
Read More -
Legislative Background
Recent Action on Prescription Drug Imports
Read More
Pro & Con
Should the House Pass H.R. 2427, the Pharmaceutical Market Access Act?
